Jerzy Gumulka
Director/Board Member bij CNS PHARMACEUTICALS, INC.
Vermogen: 15 568 $ op 31-03-2024
Profiel
Jerzy Gumulka is an Independent Director at CNS Pharmaceuticals, Inc. since 2017.
He was a Director at Moleculin LLC from 2010 to 2016.
Prior to that, he was a Technical Director at Kraton Polymers do Brasil SA from 2001 to 2015 and a Technology Manager at Kraton Polymers U.S.
LLC from 2001 to 2016.
Dr. Gumulka holds a doctorate degree from the University of Warsaw.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-04-2024 | 43 006 ( 0.51% ) | 15 568 $ | 31-03-2024 |
Actieve functies van Jerzy Gumulka
| Bedrijven | Functie | Begin |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Director/Board Member | 08-11-2017 |
Eerdere bekende functies van Jerzy Gumulka
| Bedrijven | Functie | Einde |
|---|---|---|
Kraton Polymers U.S. LLC
 Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 01-06-2016 |
Moleculin LLC
 Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Director/Board Member | 01-01-2016 |
Kraton Polymers do Brasil SA
 Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Chief Tech/Sci/R&D Officer | 01-01-2015 |
Opleiding van Jerzy Gumulka
| University of Warsaw | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Moleculin LLC
Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Health Technology |
Kraton Polymers do Brasil SA
Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Producer Manufacturing |
Kraton Polymers U.S. LLC
Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Process Industries |
